
Once-Daily Umeclidinium/Vilanterol 125/25 μg Therapy in COPD : A Randomized, Controlled Study
Keywords: AE, adverse event; BDI, Baseline Dyspnea Index; HR, hazard ratio; HRQoL, health-related quality of life; LABA, long-acting β2 agonist; LAMA, long-acting muscarinic antagonist; LSM, least squares means; PK, pharmacokinetic; SAE, serious adverse event; SGRQ